Integrating Advanced 3D Models to Empower Drug Discovery & Development

Following the excitement behind President Biden signing the FDA modernization Act 2.0 in December 2022, Hesperos and Sanofi successfully getting IND approval from organ-on-chip data for a Phase2 clinical trial, and NIH bioprinting eye tissue to develop in vitro models of AMD, the 8th Annual 3D Tissue Models Summit will return to Boston in May 2023 to reunite the community of drug discovery and development experts. This is the definitive meeting for drug developers to explore and integrate complex 3D models featuring 24+ real-life case studies across 2 dedicated tracks and their lessons learned.

What’s Unique About the 8th 3D Tissue Models Summit?

20326 - 3D Tissue Models Summit - Favicon

We are the only industry-focussed 3D tissue models summit delving into real-world applications for drug discovery and development with an industrial and regulatory environment in mind – not only for educational purpose but also form pre-competitive collaboration!

20326 - 3D Tissue Models Summit - Favicon

We provide a unique platform for drug developers to exchange challenges, inspire solutions as well as assessing the latest technologies

This May you will learn from and meet trailblazers in 3D models to revolutionize your drug discovery and development protocols, giving you greater confidence in clinical relevancy and accelerating novel treatments to patients in a safe and affordable manner!

Expert Speakers Include:

Adriana Martinez Ledo

Principal Scientist

Novartis

Anirban Chatterjee

Director, Advanced Cell Culture

MilliporeSigma

Beth Hoffman

Founder & Chief Executive Officer

Origami Therapeutics

Magdalena Kasendra

Director of Research and Development

Cincinnati Children’s Hospital

Matthias von Herrath

Vice President & Senior Medical Officer, Global Chief Medical Office

Novo Nordisk

Ratnakar Potla

Principal Scientist

Genentech

Remi Villenave

Lab Head

Roche

Richard Hanna

Associate Director Bioscience Immunology

AstraZeneca

Roger Kamm

Professor

MIT

Tuyen Nguyen

Principal Scientist

Alnylam Pharmaceuticals

Why Are Experts Attending?

“This was highly educational and exhilarating, and I would recommend it to anyone seeking both practical information and broad perspective”

- BioAnalytics Product Management, Sartorius

Sartorius_AG_Logo_old
merck

“Brilliant mix of new data/knowledge taken from a great group of experts who are so obviously excited about the future of Advanced Cell Systems" -  Head of Department, Merck

“I learned a lot for the 3D model regarding its current status, application potentials and challenges”

- Scientific Leader, GSK

gsk-logo
W4c (8)

"Nice to see people again at these in-person events - the hosts were very welcoming and everybody seemed pleased to be there" - Director, Advanced Solutions, Corning Life Sciences

Previous Attendees Include:
2023 Confirmed Partners:
Other Events in the Series: